The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
There has been an explosion of research on the potential benefits of the social neuropeptide oxytocin for a number of mental disorders including substance use disorders. Recent evidence suggests that intranasal oxytocin has both direct anti-addiction effects and pro-social effects that may facilitate engagement in psychosocial treatment for substance use disorders. We aimed to assess the tolerability of intranasal oxytocin and its effects on heroin craving, implicit association with heroin and social perceptual ability in opioid-dependent patients receiving opioid replacement therapy (ORT) and healthy control participants. We performed a randomized, double-blind, placebo-controlled, within- and between-subjects, crossover, proof-of-concept trial to examine the effects of oxytocin (40 international units) on a cue-induced craving task (ORT patients only), an Implicit Association Task (IAT), and two social perception tasks: the Reading the Mind in the Eyes Task (RMET) and The Awareness of Social Inference Test (TASIT). Oxytocin was well tolerated by patients receiving ORT but had no significant effects on craving or IAT scores. There was a significant reduction in RMET performance after oxytocin administration versus placebo in the patient group only, and a significant reduction in TASIT performance after oxytocin in both the patient and healthy control groups. A single dose of intranasal oxytocin is well tolerated by patients receiving ORT, paving the way for future investigations. Despite no significant improvement in craving or IAT scores after a single dose of oxytocin and some evidence that social perception was worsened, further investigation is required to determine the role oxytocin may play in the treatment of opioid use disorder. Methadone Oxytocin Option. ClinicalTrials.gov identifier: NCT01728909
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding and using the Implicit Association Test: III. Meta-analysis of predictive validity.
Greenwald, A. G., Poehlman, T. A., Uhlmann, E. L., & Banaji, M. R. (2009) · Journal of Personality and Social Psychology · doi:10.1037/a0015575 · Cited by 3,257
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · cited 2×
“Only male participants were recruited in order to minimize intersubject variation, as oxytocin administration may have sexually dimorphic effects (Meyer-Lindenberg et al. 2011).”
Social effects of oxytocin in humans: context and person matter
Bartz, J. A., Zaki, J., Bolger, N., & Ochsner, K. N. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.05.002 · Cited by 1,581 · cited 1×
“Given that the evidence reviewed by Bartz et al. (2011) indicates that there are substantial individual differences in oxytocin response, it is possible that trait-level individual differences may mask a significant drug effect in some subpopulations when analyzing aggregate data.”
Incentive-sensitization and addiction
Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435 · cited 1×
“, unconscious and automatic) with opioids to relapse (Marhe et al. 2013; Robinson and Berridge 2001), it would be useful to investigate if oxytocin shifts associations away from opioid-related stimuli, in addition to more direct measures of tolerance, withdrawal, and craving.”
Oxytocin Increases Retention of Social Cognition in Autism
Hollander, E., Bartz, J., Chaplin, W., Phillips, A., Sumner, J., Soorya, L., Anagnostou, E., & Wasserman, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.030 · Cited by 693 · cited 1×
“hypothalamic neuropeptide) in the treatment of psychiatric illness, including autism (Hollander et al. 2007), social anxiety disorder (Guastella et al.”
Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice
Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M., & Landgraf, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.003 · Cited by 511 · cited 2×
“Previous studies have shown that intranasal oxytocin enters the CSF in animals (Neumann et al. 2013) and humans (Striepens et al. 2013) and begins to have physiological effects within 30 min, which last for a minimum of 90 min (Norman et al. 2011).”
Neural systems and cue-induced cocaine craving
Bonson, K. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00371-2 · Cited by 507 · cited 2×
“Cue-induced craving (patients only) This task assesses heroin craving in response to a 1-min video of documentary footage from BBlack Tar Heroin: The Dark End of the Street^ (Okazaki 1999) depicting the use of black tar heroin (needle preparation, cooking, intravenous injection), as exposure to drug-related cues have…”
Striepens, N., Kendrick, K. M., Hanking, V., Landgraf, R., Wüllner, U., Maier, W., & Hurlemann, R. (2013) · Scientific Reports · doi:10.1038/srep03440 · Cited by 452 · cited 1×
“Previous studies have shown that intranasal oxytocin enters the CSF in animals (Neumann et al. 2013) and humans (Striepens et al. 2013) and begins to have physiological effects within 30 min, which last for a minimum of 90 min (Norman et al. 2011).”
Cited by
Oxytocin reduces alcohol cue-reactivity in alcohol-dependent rats and humans
Hansson, A. C., Koopmann, A., Uhrig, S., Bühler, S., Domi, E., Kiessling, E., Ciccocioppo, R., Froemke, R. C., Grinevich, V., Kiefer, F., et al. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.257 · Cited by 109
Oxytocin enhances cognitive control of food craving in women
Striepens, N., Schröter, F., Stoffel‐Wagner, B., Maier, W., Hurlemann, R., & Scheele, D. (2016) · Human Brain Mapping · doi:10.1002/hbm.23308 · Cited by 63
“…in alcohol-dependent patients [Pedersen et al., 2013], two recent studies also report divergent effects of intranasal OXT in opioid-dependent individuals [Woolley et al., 2016] and subjects with alcohol use disorder [Mitchell et al., 2016], with OXT reducing only cue-induced alcohol cravings.”
Nikolaou, K., Kapoukranidou, D., Ndungu, S., Floros, G., & Kovatsi, L. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1312644 · Cited by 18
Metadata
- Authors
- Woolley, J. D., Arcuni, P. A., Stauffer, C. S., Fulford, D., Carson, D. S., Batki, S., & Vinogradov, S.
- Venue
- Psychopharmacology
- Published
- 2016-05-03
- Volume
- 233
- Issue
- 13
- Pages
- 2571-2580
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2346027802
- Cited by
- 45
- References
- 26
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study. https://app.cochat.ai/papers/10.1007/s00213-016-4308-8
- The paper
- Woolley, J. D., Arcuni, P. A., Stauffer, C. S., Fulford, D., Carson, D. S., Batki, S., & Vinogradov, S. (2016). The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study. Psychopharmacology. https://doi.org/10.1007/s00213-016-4308-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.